Terminated NA INTERVENTIONAL 2-arm NCT05826704

Exploring the Effects of Lactobacillus Paracasei PS23 on Workplace-related Stress Symptoms Among Office Workers

Sponsor: Bened Biomedical Co., Ltd.

Conditions Stress

Interventions Probiotics

Updated 3 times since 2023 Last updated: Aug 13, 2024 Started: Dec 30, 2022 Primary completion: Dec 31, 2023 Completion: Apr 30, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The company had to re-decorate

Other terminated trials from Bened Biomedical Co., Ltd.

More terminations from Bened Biomedical Co., Ltd.

Other Stress trials with similar outcome

Browse all Stress trials

Listed as NCT05826704, this NA trial focuses on Stress and remains terminated or withdrawn. Sponsored by Bened Biomedical Co., Ltd., it has been updated 3 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Terminated NA

Status: Recruiting → Terminated
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
May 2023 — Jul 2024 [monthly]

Recruiting NA

First recorded

Dec 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bened Biomedical Co., Ltd.
Mackay Memorial Hospital

Data source: Mackay Memorial Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taipei, Taiwan